Literature DB >> 26990991

Structural Basis for the Altered PAM Specificities of Engineered CRISPR-Cas9.

Seiichi Hirano1, Hiroshi Nishimasu2, Ryuichiro Ishitani1, Osamu Nureki3.   

Abstract

The RNA-guided endonuclease Cas9 cleaves double-stranded DNA targets bearing a PAM (protospacer adjacent motif) and complementarity to the guide RNA. A recent study showed that, whereas wild-type Streptococcus pyogenes Cas9 (SpCas9) recognizes the 5'-NGG-3' PAM, the engineered VQR, EQR, and VRER SpCas9 variants recognize the 5'-NGA-3', 5'-NGAG-3', and 5'-NGCG-3' PAMs, respectively, thus expanding the targetable sequences in Cas9-mediated genome editing applications. Here, we present the high-resolution crystal structures of the three SpCas9 variants in complexes with a single-guide RNA and its altered PAM-containing, partially double-stranded DNA targets. A structural comparison of the three SpCas9 variants with wild-type SpCas9 revealed that the multiple mutations synergistically induce an unexpected displacement in the phosphodiester backbone of the PAM duplex, thereby allowing the SpCas9 variants to directly recognize the altered PAM nucleotides. Our findings explain the altered PAM specificities of the SpCas9 variants and establish a framework for further rational engineering of CRISPR-Cas9.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26990991     DOI: 10.1016/j.molcel.2016.02.018

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  36 in total

1.  Production of knock-in mice in a single generation from embryonic stem cells.

Authors:  Hideki Ukai; Hiroshi Kiyonari; Hiroki R Ueda
Journal:  Nat Protoc       Date:  2017-11-16       Impact factor: 13.491

Review 2.  CRISPR-Cas9 genome engineering: Treating inherited retinal degeneration.

Authors:  Erin R Burnight; Joseph C Giacalone; Jessica A Cooke; Jessica R Thompson; Laura R Bohrer; Kathleen R Chirco; Arlene V Drack; John H Fingert; Kristan S Worthington; Luke A Wiley; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Prog Retin Eye Res       Date:  2018-03-22       Impact factor: 21.198

Review 3.  Multigene CRISPR/Cas9 genome editing of hybrid proline rich proteins (HyPRPs) for sustainable multi-stress tolerance in crops: the review of a promising approach.

Authors:  Banashree Saikia; Sanjay Singh; Johni Debbarma; Natarajan Velmurugan; Hariprasanna Dekaboruah; Kallare P Arunkumar; Channakeshavaiah Chikkaputtaiah
Journal:  Physiol Mol Biol Plants       Date:  2020-04-20

Review 4.  Emerging Gene Therapies for Genetic Hearing Loss.

Authors:  Hena Ahmed; Olga Shubina-Oleinik; Jeffrey R Holt
Journal:  J Assoc Res Otolaryngol       Date:  2017-08-16

5.  Structural Basis for the Altered PAM Recognition by Engineered CRISPR-Cpf1.

Authors:  Hiroshi Nishimasu; Takashi Yamano; Linyi Gao; Feng Zhang; Ryuichiro Ishitani; Osamu Nureki
Journal:  Mol Cell       Date:  2017-06-06       Impact factor: 17.970

6.  Directed evolution studies of a thermophilic Type II-C Cas9.

Authors:  Travis H Hand; Anuska Das; Hong Li
Journal:  Methods Enzymol       Date:  2018-12-28       Impact factor: 1.600

7.  Precise DNA cleavage using CRISPR-SpRYgests.

Authors:  Kathleen A Christie; Jimmy A Guo; Rachel A Silverstein; Roman M Doll; Megumu Mabuchi; Hannah E Stutzman; Jiecong Lin; Linyuan Ma; Russell T Walton; Luca Pinello; G Brett Robb; Benjamin P Kleinstiver
Journal:  Nat Biotechnol       Date:  2022-10-06       Impact factor: 68.164

8.  Single nucleotide editing without DNA cleavage using CRISPR/Cas9-deaminase in the sea urchin embryo.

Authors:  Saba Shevidi; Alicia Uchida; Natalie Schudrowitz; Gary M Wessel; Mamiko Yajima
Journal:  Dev Dyn       Date:  2017-10-13       Impact factor: 3.780

Review 9.  CRISPR RNA-guided autonomous delivery of Cas9.

Authors:  Royce A Wilkinson; Coleman Martin; Artem A Nemudryi; Blake Wiedenheft
Journal:  Nat Struct Mol Biol       Date:  2018-12-31       Impact factor: 15.369

10.  Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants.

Authors:  Russell T Walton; Kathleen A Christie; Madelynn N Whittaker; Benjamin P Kleinstiver
Journal:  Science       Date:  2020-03-26       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.